Us District Court Upholds Forest Laboratories Patent
Long Island Business News › August 20, 2004
Linked as:
Summary
Forest Laboratories has staved off a challenge to the patent of its antidepressant drug Celexa by Brisbane, Australia-based Alphapharm.
The U.S. District Court in the District of Columbia dismissed the challenge from Alphapharm, ruling that the U.S. Food and Drug Administration acted properly when it denied Alphapharm's application to make and market its own version of the drug.See the full content of this document
Extract
Us District Court Upholds Forest Laboratories Patent
Celexa a...
See the full content of this document
Sponsored links
